Cutting edge: Ly49A inhibits TCR/CD3-induced apoptosis and IL-2 secretion

被引:32
作者
Roger, J [1 ]
Chalifour, A [1 ]
Lemieux, S [1 ]
Duplay, P [1 ]
机构
[1] Univ Quebec, Inst Armand Frappier, Inst Natl Res Sci, Laval, PQ H7V 1B7, Canada
关键词
D O I
10.4049/jimmunol.167.1.6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To evaluate the importance of Ly49A on TCR-induced cellular events, we established clones of the 1F2 T cell hybridoma expressing either Ly49A or a chimeric version, Ly49A/H, where the Ly49A cytoplasmic domain has been replaced by the Ly49H cytoplasmic domain. Ligation of Ly49A, but not Ly49A/H, with its ligand H-2D(d) or anti-Ly49A mAbs caused a specific inhibition of TCR/CD3-induced IL-2 secretion. Moreover, flow cytometry analysis of hypodiploid DNA and annexin V binding revealed that ligation of Ly49A protected cells from apoptosis induced by anti-CD3 mAbs or Ag. In contrast, ligation of the Ly49A/H chimeric receptor had no antiapoptotic effect. In addition, engagement of Ly49A selectively inhibited TCR-induced Fas ligand expression whereas TCR-induced Fas expression was not significantly affected. Expression of Ly49 inhibitory receptors on T cells may represent an important mechanism for the regulation of T cell survival in vivo by inhibiting TCR-induced apoptosis and IL-2 secretion.
引用
收藏
页码:6 / 10
页数:5
相关论文
共 29 条
[1]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[2]   Transgenic expression of Ly49A on T cells impairs a specific antitumor response [J].
Brawand, P ;
Lemonnier, FA ;
MacDonald, HR ;
Cerottini, JC ;
Held, W .
JOURNAL OF IMMUNOLOGY, 2000, 165 (04) :1871-1876
[3]   CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS [J].
BRUNNER, T ;
MOGIL, RJ ;
LAFACE, D ;
YOO, NJ ;
MAHBOUBI, A ;
ECHEVERRI, F ;
MARTIN, SJ ;
FORCE, WR ;
LYNCH, DH ;
WARE, CF ;
GREEN, DR .
NATURE, 1995, 373 (6513) :441-444
[4]  
Coles MC, 2000, EUR J IMMUNOL, V30, P236, DOI 10.1002/1521-4141(200001)30:1<236::AID-IMMU236>3.0.CO
[5]  
2-X
[6]   A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR [J].
Daniel, C ;
Horvath, S ;
Allen, PM .
IMMUNITY, 1998, 8 (05) :543-552
[7]  
Daniel C, 1998, J IMMUNOL, V160, P3244
[8]   Cutting edge: The class II transactivator prevents activation-induced cell death by inhibiting Fas ligand gene expression [J].
Gourley, TS ;
Chang, CH .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :2917-2921
[9]   Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection [J].
Held, W ;
Cado, D ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :2037-2041
[10]   FAS(CD95) FASL INTERACTIONS REQUIRED FOR PROGRAMMED CELL-DEATH AFTER T-CELL ACTIVATION [J].
JU, ST ;
PANKA, DJ ;
CUI, HL ;
ETTINGER, R ;
ELKHATIB, M ;
SHERR, DH ;
STANGER, BZ ;
MARSHAKROTHSTEIN, A .
NATURE, 1995, 373 (6513) :444-448